(1 Vote)

Steering Committee

The high profile committee guiding the UK PGx Network



Prof Sir Munir Pirmohamed - NHS Chair of Pharmacogenetics, University of Liverpool

Dr Christine McNamee - Network Manager, University of Liverpool

Prof Ann Daly - Professor of Pharmacogenetics, Newcastle University

Prof Chris Chamberlain - Head of Experimental Medicine, Global Early Development, Merck Healthcare

Prof Doris-Ann Williams - Chief Executive, BIVDA

Eddie Blair - Respiratory Disease Biomarker Lead, UCB

Dr Edward Blandford - Genomics Science and Emerging Technologies, Department of Health

Dr Ellen McDonagh - Head of Curation, Genomics England

Prof Ewan Pearson - Professor of Diabetic Medicine, Dundee University

Dr Fiona Carragher - Deputy Chief Scientific Officer, NHS England

Dr Karen Spink - Innovation Lead (Precision Medicine), Innovate UK

Dr Krishna Prasad - Clinical Assessor, MHRA

Dr Louise Leong - Director Science Relations, AstraZeneca

Dr Michael Dunn - Science Portfolio Manager, Wellcome Trust

Dr Philippa Brice - External Affairs Director, PHG Foundation

Dr Richard Evans - Programme Manager, MRC

Dr Shahid Hanif - Head of Health Data & Outcomes, ABPI



The Pharmacogenetics and Stratified Medicines Network was set up to facilitate access to, or interaction with, the UK’s stratified medicine clinical and research base activity, and support new collaborations and innovation with the industry base.

Terms of Reference

To help define and formulate the remit and role of the UK Pharmacogenetics and Stratified Medicines network

To disseminate information about the network, to encourage membership and promote attendance to events

To advise on the programme for the annual meeting of the network

To advise on how the network can interact and synergise with all UK stakeholders involved in the field of stratified medicine

To identify funding opportunities for UK pharmacogenetics and stratified medicines researchers, including in the EU and US

To advise on the development and content of the network website

To facilitate interaction and engagement across the life science community which researches, develops, evaluates, commissions, and uses stratified medicine.

To further expand the network across Europe, and then on as a global organisation.

To proactively develop policies to strengthen the UK environment, and global standing, for stratified medicine.

Contact Us

University of Liverpool

Block A: Waterhouse Buildings

1-5 Brownlow Street

Liverpool L69 3GL


Follow us